English  |  正體中文  |  简体中文  |  Total items :2815474  
Visitors :  27453881    Online Users :  119
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lane hy"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-43 of 43  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2023-10 Adjunctive transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer's disease: A randomized, double-blind, placebo-controlled trial Lane, HY;Wang, SH;Lin, CH
國家衛生研究院 2023-08 Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline Lane, HY;Wang, SH;Lin, CH
高雄醫學大學 2014 以肌氨酸治療高功能自閉症孩童之臨床藥物試驗  楊品珍;藍先元;顏正芳;張震霖 ; Yang, P;Lane, HY;Yen, CF;CL , Chang
國家衛生研究院 2013-10 Prognostic factors of radiofrequency ablation for hepatocellular carcinoma: A nationwide cohort study Lee, TY;Ho, HJ;Kuo, KN;Lin, JT;Lane, HY;Wu, MS;Wu, CY
中國醫藥大學 2011-12 The risk of temporomandibular disorder in patients with depression: a population-based cohort study. Liao CH; Chang CS; Chang SN; Lane HY; Lyu SY; Morisky DE; Sung FC.
國家衛生研究院 2006-11 Glutamate decarboxylase genes and alcoholism in Han Taiwanese men Loh, EW; Lane, HY; Chen, CH; Chang, PS; Ku, LW; Wang, KHT; Cheng, ATA
中國醫藥大學 2005 Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study Lane, HY; Chang, YC; Liu, YC; Chiu, CC; Tsai, GE
中國醫藥大學 2005 Expanded trinucleotide repeats in the TBP/SCA17 gene mapped to chromosome 6q27 are associated with schizophrenia Chen, CM; Lane, HY; Wu, YR; Ro, LS; Chen, FL; Hung, WL; Hou, YT; Lin, CY; Huang, SY; Chen, IC; Soong, BW; Li, ML; Hsieh-Li, HM; Su, MT; Lee-Chen, GJ
中國醫藥大學 2005 Expanded trinucleotide repeats in the TBP/SCA17 gene mapped to chromosome 6q27 are associated with schizophrenia Chen, CM; Lane, HY; Wu, YR; Ro, LS; Chen, FL; Hung, WL; Hou, YT; Lin, CY; Huang, SY; Chen, IC; Soong, BW; Li, ML; Hsieh-Li, HM; Su, MT; Lee-Chen, GJ
中國醫藥大學 2005 Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH
中國醫藥大學 2005 A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan Sun, HS; Fann, CSJ; Lane, HY; Chang, YT; Chang, CJ; Liu, YL; Cheng, ATA
中國醫藥大學 2005 Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics Lane, HY; Lee, CC; Liu, YC; Chang, WH
中國醫藥大學 2005 Regular-dose risperidone on QTc intervals Chiu, CC; Chang, WH; Huang, MC; Chin, YW; Lane, HY
中國醫藥大學 2005 Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH
中國醫藥大學 2005 Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics Lane, HY; Lee, CC; Liu, YC; Chang, WH
中國醫藥大學 2004 Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome Su, KP; Lane, HY; Chuang, CL; Chen, KP; Shen, WW
中國醫藥大學 2004 Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH
中國醫藥大學 2004 Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML
中國醫藥大學 2004 Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances Lu, ML; Lane, HY; Lin, SK; Chen, KP; Chang, WH
中國醫藥大學 2004 Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH
中國醫藥大學 2004 Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH
中國醫藥大學 2004 Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N
中國醫藥大學 2004 Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH
中國醫藥大學 2004 Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH
中國醫藥大學 2004 Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N
中國醫藥大學 2004 Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH
中國醫藥大學 2004 Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML
中國醫藥大學 2003 Adjunctive fluvoxamine with clozapine Lu, ML; Lane, HY
中國醫藥大學 2003 QTc intervals are not prolonged in young healthy patients with recommended dosage of risperidone Chiu, CC; Lane, HY; Huang, MC; Chang, WH
中國醫藥大學 2003 Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH
中國醫藥大學 2003 Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH
中國醫藥大學 2003 Refining pharmacogenetic research in schizophrenia: Control for patient-related variables Lane, HY; Chang, YC; Huang, CL; Chang, WH
中國醫藥大學 2003 Refining pharmacogenetic research in schizophrenia: Control for patient-related variables Lane, HY; Chang, YC; Huang, CL; Chang, WH
國立臺灣大學 2002-05 Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study. Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH
中國醫藥大學 2002 Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: A pilot study Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH
中國醫藥大學 2002 Dosing strategies of clozapine-fluvoxamine cotreatment Lu, ML; Lane, HY; Jann, MW; Chang, WH
中國醫藥大學 2002 Fluvoxamine-clozapine interaction: Time-dependent? Lu, ML; Lane, HY; Chang, WH
中國醫藥大學 2002 Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH
中國醫藥大學 2002 Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: Analyses with rigorous statistics Lane, HY; Chang, YC; Chiu, CC; Chen, TT; Lee, SH; Chang, WH
中國醫藥大學 2002 Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH
國立臺灣大學 2001-05 A double-blinded study on efficacy and safety of olanzapine versus haloperidol in the treatment of schizophrenic patients. Hong, CJ; Cheng, JJ; Hwang, TJ; Chen, YS; Guo, SC; Lane, HY; Lee, YC; Zhang, F; Chnag, WH; Tran, P; Hwu, HG
臺北醫學大學 1999 Seizures after Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects? 蘇冠賓; Lane HY; Su KP; Chang WH
臺北醫學大學 1998 Elevated plasma clozapine concentrations after phenobarbital discontinuation 蘇冠賓; Lane HY; Su KP; Chang WH

Showing items 1-43 of 43  (1 Page(s) Totally)
1 
View [10|25|50] records per page